Showing results (1191-1200 of 1,283) with videos related to
Sort By:
Pageof 129
Journal of Medicinal Chemistry|June 23, 2016
Discovery of 1-(1H-Pyrazolo[4,3-c]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of CancersJongwon Lim, Elizabeth H Kelley, Joey L Methot, et al.Journal of the American Chemical Society|April 26, 2026
Photofracking-Assisted Enhancement of Solid-State Photochemical Reactivity: α-Azido-5-phenyl-2,4-dienoate DerivativesUpasana Banerjee, Janaka P K Kavikarage, Fiona J Wasson, et al.The Israel Medical Association Journal : IMAJ|May 11, 2010
First report of screening an asymptomatic population for cancer: the yield of an integrated cancer prevention centerBen Boursi, Hanan Guzner-Gur, Yaquv Mashich, et al.Molecular Cancer Research : MCR|February 28, 2014
Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumorsMichael S Rogers, Katherine Novak, David Zurakowski, et al.Voenno-Meditsinskii Zhurnal|February 15, 2012
[Experience of left ventricular assist device "Incor" as "bridge to recovery" implantation in patients with end stage congestive heart failure]G G Khubulava, E V Ivchenko, A A Paĭvin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistanceGeorge N Naumov, Monique B Nilsson, Tina Cascone, et al.European Journal of Internal Medicine|January 15, 2013
One stop screening for multiple cancers: the experience of an integrated cancer prevention centerTal Sella, Ben Boursi, Amira Gat-Charlap, et al.Journal of Biomolecular Screening|July 28, 2016
Development of a High-Throughput Gene Expression Screen for Modulators of RAS-MAPK Signaling in a Mutant RAS Cellular ContextBryan Severyn, Thi Nguyen, Michael D Altman, et al.Plos Computational Biology|July 14, 2021
COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severityVladimir Naumov, Evgeny Putin, Stefan Pushkov, et al.Cancer Research|December 20, 2007
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinibJeffrey A Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale, et al.Pageof 129